Our Initiatives
CINTA: Center for Innovative NeuroTech Advancement
About CINTA
Cimit’s Center for Innovative NeuroTech Advancement (CINTA) program rapidly transforms emerging technologies into commercially viable, clinically focused solutions for disorders of the nervous system.
This program leverages Cimit’s leadership in developing critical health innovations for over 25 years. Our contributions have evolved from providing funding and facilitating projects, to spearheading multidisciplinary collaborations, to overseeing the entire health innovation process and everywhere in between.
CINTA is supported by the NIH Blueprint MedTech Program under U54EB033650.
Who We Are
Principal Investigators
Steven Schachter MD
PI for CINTA; Chief Academic Officer & Director Neurotechnology, Cimit; Chief, Rapid Acceleration of Diagnostics (RADx® Tech); Professor of Neurology, Harvard Medical School.
Paolo Bonato, Ph.D
Co-PI for CINTA; Director Motion Analysis Laboratory Spaulding Rehabilitation Hospital; Associate Professor Department of Physical Medicine and Rehabilitation, Harvard Medical School; Adjunct Professor of Biomedical Engineering at the MGH Institute of Health Professions; Associate Faculty Member at the Wyss Institute for Biologically Inspired Engineering; Adjunct Professor of Electrical and Computer Engineering at Northeastern University.
View the full team
Core Leads
Michael Dempsey
Subprojects Core Lead for CINTA
Tracy McMahon
Outreach Core Lead for CINTA
Susan Moreira
Evaluation Core Lead for CINTA
Paul Tessier
Administrative Core Lead for CINTA
Cinta Staff
Sophie Beckman
Program Coordinator
Marshall Collins
Director of Information Systems
John Collins, PHD
Director of Innovation Platforms
Cecile Davis
Administrative Assistant
Andrea Depatie
Chief Financial & Information Officer
Jamal Farouk
Finance Manager
Kerry DeVito, MFA
Communications Coordinator
Michele Liston
Director of Operations
Santosh Savaliya, MA
Operations Analyst
Core Leads
Michael Dempsey
Subprojects Core Lead for CINTA; Entrepreneur-in-Residence, Consultant Innovator, Cimit
Title or headline here
Description etc here
Penny Ford-Carleton, RN, MS, MPA, MSC
Description etc here
Title or headline here
Description etc here
CINTA Staff
John Collins, PhD
Director Innovation Platforms, Cimit and CINTA
John Collins, PhD
Director Innovation Platforms, Cimit and CINTA
John Collins, PhD
Director Innovation Platforms, Cimit and CINTA
John Collins, PhD
Director Innovation Platforms, Cimit and CINTA
John Collins, PhD
Director Innovation Platforms, Cimit and CINTA
John Collins, PhD
Director Innovation Platforms, Cimit and CINTA
John Collins, PhD
Director Innovation Platforms, Cimit and CINTA
John Collins, PhD
Director Innovation Platforms, Cimit and CINTA
John Collins, PhD
Director Innovation Platforms, Cimit and CINTA
John Collins, PhD
Director Innovation Platforms, Cimit and CINTA
John Collins, PhD
Director Innovation Platforms, Cimit and CINTA
John Collins, PhD
Director Innovation Platforms, Cimit and CINTA
CINTA News
The latest CINTA news, announcements and funding opportunities.
Events and Webinars
Webinar
Cycle 6 Informational Webinar
Have questions about the current funding opportunity? Watch our informational webinar to better understand the program and application process.
Event
Spring 2024 Fireside Chat Series
Co-hosted by NeuroTech Harbor and Cimit's CINTA, through the NIH's Blueprint MedTech program. Hear from four neurotech experts and innovators.
Event
Inaugural Fireside Chat Series with NeuroTech Innovation Leaders
Fireside chats with industry leaders in neurotechnology, medicine, medtech and manufacturing.
Watch the recordings
Resources
Georgia Tech HomeLab
Georgia Tech’s HomeLab initiative provides the capability to conduct in-home research that supports the development of innovative technologies that promote health, wellness, and independence for older adults. HomeLab brings together a multidisciplinary team of scientists and engineers and a community of older adults interested in participating in research.
Institute for Electronics and Nanotechnology at Georgia Tech
IEN operates state-of-the-art electronics and nanotechnology core facilities at Georgia Tech, offering a broad range of fabrication and characterization capabilities for activities from basic discovery to prototype realization. Part of the NSF-funded National Nanotechnology Coordinated Infrastructure (NNCI), the core facilities are open to users from academia, industry, and government labs. The IEN core facilities enable top-down, lithography-based micro/nano-fabrication, bottom-up material synthesis, high-resolution imaging and advanced material analysis, as well as work at the intersection of life sciences and nanotechnology.
Spaulding Rehabilitation Hospital Motion Analysis Lab
The Motion Analysis Lab (MAL) at Spaulding Rehabilitation Hospital brings state-of the art technology and internationally-recognized expertise to the study and treatment of mobility-limiting conditions, including cerebral palsy, stroke, traumatic brain injury, spinal cord injury and Parkinson’s Disease. Dedicated to helping patients regain and retain their independence, the lab is one of the country’s pre-eminent research labs in the development of ground-breaking robotics and wearable technology for patient rehabilitation. In studying the biomechanics of human movement, our goal is to find the most effective ways to get patients moving again.
Spaulding Neuromodulation Center
The Spaulding Neuromodulation Center is dedicated to the rigorous scientific exploration that aims to improve the physical and mental wellness. Led by Dr. Felipe Fregni, the Center aims to investigate diverse techniques of non-invasive brain stimulation, including the mechanisms of action and their use for rehabilitation and pain modulation.
The Office of Science and Engineering Laboratories (OSEL) is composed of scientists and engineers who have a broad diversity of expertise from microbiology to artificial intelligence and machine learning. We are all dedicated to promoting innovation for the development of new lifesaving medical devices.
We are organized into approximately 20 program areas, running about 150 research projects through our four main technical divisions: Applied Mechanics (DAM), Biomedical Physics (DBP), Biology Chemistry and Materials Science (DBCMS) and Imaging Diagnostics and Software Reliability (DIDSR).
FDA Office of Science and Engineering Labs
Blueprint Med Tech Incubator Hub Program
NIH Blueprint MedTech has funded two Incubator Hubs, NeuroTech Harbor (NTH) and CINTA (Center for Innovative NeuroTech Advancement), to solicit, evaluate, and oversee technology development projects. The Hubs will provide direct funding and in-kind resources to innovator teams to develop and de-risk these groundbreaking technologies to the point where additional investments are warranted from industry partners, investors, and government. The Hubs will post solicitations each year to the Blueprint Neurotech website.
Two kinds of awards may be issued for applications submitted to this solicitation.
- Optimizer awards will rarely exceed $500,000 in direct costs per year for a period of up to 4 years. In addition to monetary support, awardees will receive mentoring and resources and support services necessary for translation will be available as outlined above.
- Seedling awards provide support for six months, a $25,000 stipend, and $25,000 to hire subject matter experts. Mentors will work with awardees throughout the project to help resolve specifically identified gap(s) on the path to commercialization.
U54EB033650: About CINTA (Center for Innovative NeuroTech Advancement)
CINTA is a program of the Cimit, an organization that works alongside groups dedicated to advancing groundbreaking solutions by delivering the expertise needed every step of the way.
U54EB033664: About NeuroTech Harbor (NTH)
NeuroTech Harbor’s mission is to support the development of real-world solutions to alleviate human suffering from neurological conditions. This is made possible through a partnership between Johns Hopkins University and Howard University, and a new NIH Initiative that commits to equitech-based values of inclusivity, equity and accessibility in all its endeavors.
By the conclusion of CINTA or NTH funding, it is anticipated that all projects will be ready for entry into the companion Translator solicitations from NIH:
Blueprint MedTech Awardees
The NIH’s Blueprint MedTech program continues to issue many Optimizer and Seedling awards. These projects are administered by the two Blueprint MedTech Incubator Hubs—Cimit’s CINTA and NeuroTech Harbor.
Blueprint MedTech
NIH Blueprint MedTech has funded two Incubator Hubs, NeuroTech Harbor (NTH) and CINTA (Center for Innovative NeuroTech Advancement), to solicit, evaluate, and oversee technology development projects.